Clinical Trial Update: A Study to Evaluate the Effect of a Single Dose of CNTO 136 (Sirukumab) on CYP450 Enzyme Activities After Subcutaneous Administration in Patients With Rheumatoid Arthritis [Phase 1]

View source ↗

Summary

A Phase 1 study evaluated the effect of a single subcutaneous dose of sirukumab on CYP450 enzyme activities in rheumatoid arthritis patients; the trial has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Sirukumab (sirukumab)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Arthritis, Rheumatoid | Phase 1 | Status: COMPLETED